Company registration number 04817883 (England and Wales)
NEWBRIDGE (HEALTHCARE) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
NEWBRIDGE (HEALTHCARE) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
NEWBRIDGE (HEALTHCARE) LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
2
157,534
Tangible assets
4
341,562
381,371
Investments
5
4,915,558
4,915,558
5,257,122
5,454,463
Current assets
Stocks
308,422
326,496
Debtors
7
2,190,716
2,248,122
Cash at bank and in hand
380,618
530,749
2,879,756
3,105,367
Creditors: amounts falling due within one year
8
(2,232,014)
(7,611,410)
Net current assets/(liabilities)
647,742
(4,506,043)
Total assets less current liabilities
5,904,864
948,420
Provisions for liabilities
(20,573)
(28,010)
Net assets
5,884,291
920,410
Capital and reserves
Called up share capital
220
220
Profit and loss reserves
5,884,071
920,190
Total equity
5,884,291
920,410
NEWBRIDGE (HEALTHCARE) LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2025
30 September 2025
- 2 -

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 19 June 2026 and are signed on its behalf by:
Mr V Bhatia
Director
Company registration number 04817883 (England and Wales)
NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information

Newbridge (Healthcare) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 5, Crown Point Industrial Park, King Street, Denton, Manchester, United Kingdom, M34 6PF.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 5 years.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% per annum on cost
Plant and equipment
20% per annum on cost
Fixtures and fittings
20% per annum on cost
Website development
33.3% per annum on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.11

Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand.

NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.12

Related party exemption

The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102,' The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
34
33
3
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2024 and 30 September 2025
3,317,412
Amortisation and impairment
At 1 October 2024
3,159,878
Amortisation charged for the year
157,532
At 30 September 2025
3,317,410
Carrying amount
At 30 September 2025
2
At 30 September 2024
157,534
4
Tangible fixed assets
Freehold land and buildings
Plant and equipment
Fixtures and fittings
Website development
Total
£
£
£
£
£
Cost
At 1 October 2024
264,527
59,366
276,746
32,856
633,495
Additions
-
0
10,264
3,885
-
0
14,149
At 30 September 2025
264,527
69,630
280,631
32,856
647,644
Depreciation and impairment
At 1 October 2024
24,877
16,312
178,079
32,856
252,124
Depreciation charged in the year
5,291
13,926
34,741
-
0
53,958
At 30 September 2025
30,168
30,238
212,820
32,856
306,082
NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
4
Tangible fixed assets
Freehold land and buildings
Plant and equipment
Fixtures and fittings
Website development
Total
£
£
£
£
£
(Continued)
- 6 -
Carrying amount
At 30 September 2025
234,359
39,392
67,811
-
0
341,562
At 30 September 2024
239,650
43,054
98,667
-
0
381,371
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
4,915,558
4,915,558
6
Subsidiaries

Details of the company's subsidiaries at 30 September 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Cluister Limited
England and Wales
Ordinary A
0
99.50
Garrett Holdings Ltd
England and wales
Ordinary
100.00
-
Kelvinwell Limited
England and Wales
Ordinary
100.00
-
S. F. Wain & Sons Limited
England and Wales
Ordinary
100.00
-
Vivake Bhatia Limited
England and Wales
Ordinary
100.00
-
Bailey & Garrett (Chemists) Limited
England and Wales
Ordinary
0
100.00
Mai's Pharmacy Ltd
England and Wales
Ordinary
100.00
-
John Hugall Limited
England and Wales
Ordinary
100.00
-
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
568,870
568,311
Other debtors
1,579,595
1,662,466
Prepayments and accrued income
42,251
17,345
2,190,716
2,248,122
NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 7 -
8
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
723,588
1,049,128
Amounts owed to group undertakings
1,264
5,199,234
Taxation and social security
104,869
122,392
Other creditors
1,402,293
1,240,656
2,232,014
7,611,410
9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
268,848
296,728
10
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Entities with common controlling shareholders and directors
1,203,838
1,235,098

The above disclosed amount is included within the other creditors due in one year. The loan is unsecured, interest free and repayable on demand.

11
Directors' transactions

The closing balance is the total loans taken by the directors. This was the maximum amount of the loan outstanding at any point in the year. Interest on the loans was charged at the official rate.

NEWBRIDGE (HEALTHCARE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
11
Directors' transactions
(Continued)
- 8 -
Advances
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Mr V Bhatia - Loans
2.25
77,594
267,928
1,772
(330,500)
16,794
Mr EH Bar-Ilan - Loans
2.25
1,141,084
312,243
26,190
(330,528)
1,148,989
1,218,678
580,171
27,962
(661,028)
1,165,783
12
Parent company

The company's immediate and ultimate parent is Newbridge Healthcare Holdings Limited, a company incorporated in England and Wales.

 

The ultimate controlling parties of the company are the two directors, Mr V Bhatia and Mr EH Bar-Ilan by virtue of their shareholdings in Newbridge Healthcare Holdings Limited.

2025-09-302024-10-01falsefalsefalse19 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr V BhatiaMr EH Bar-Ilan048178832024-10-012025-09-30048178832025-09-30048178832024-09-3004817883core:NetGoodwill2025-09-3004817883core:NetGoodwill2024-09-3004817883core:LandBuildingscore:OwnedOrFreeholdAssets2025-09-3004817883core:PlantMachinery2025-09-3004817883core:FurnitureFittings2025-09-3004817883core:ComputerEquipment2025-09-3004817883core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-3004817883core:PlantMachinery2024-09-3004817883core:FurnitureFittings2024-09-3004817883core:ComputerEquipment2024-09-3004817883core:CurrentFinancialInstrumentscore:WithinOneYear2025-09-3004817883core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-3004817883core:CurrentFinancialInstruments2025-09-3004817883core:CurrentFinancialInstruments2024-09-3004817883core:ShareCapital2025-09-3004817883core:ShareCapital2024-09-3004817883core:RetainedEarningsAccumulatedLosses2025-09-3004817883core:RetainedEarningsAccumulatedLosses2024-09-3004817883bus:Director12024-10-012025-09-3004817883core:Goodwill2024-10-012025-09-3004817883core:LandBuildingscore:OwnedOrFreeholdAssets2024-10-012025-09-3004817883core:PlantMachinery2024-10-012025-09-3004817883core:FurnitureFittings2024-10-012025-09-3004817883core:ComputerEquipment2024-10-012025-09-30048178832023-10-012024-09-3004817883core:NetGoodwill2024-09-3004817883core:NetGoodwill2024-10-012025-09-3004817883core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-3004817883core:PlantMachinery2024-09-3004817883core:FurnitureFittings2024-09-3004817883core:ComputerEquipment2024-09-30048178832024-09-3004817883core:Subsidiary12024-10-012025-09-3004817883core:Subsidiary22024-10-012025-09-3004817883core:Subsidiary32024-10-012025-09-3004817883core:Subsidiary42024-10-012025-09-3004817883core:Subsidiary52024-10-012025-09-3004817883core:Subsidiary62024-10-012025-09-3004817883core:Subsidiary72024-10-012025-09-3004817883core:Subsidiary82024-10-012025-09-3004817883core:Subsidiary112024-10-012025-09-3004817883core:Subsidiary222024-10-012025-09-3004817883core:Subsidiary332024-10-012025-09-3004817883core:Subsidiary442024-10-012025-09-3004817883core:Subsidiary552024-10-012025-09-3004817883core:Subsidiary662024-10-012025-09-3004817883core:Subsidiary772024-10-012025-09-3004817883core:Subsidiary882024-10-012025-09-3004817883bus:PrivateLimitedCompanyLtd2024-10-012025-09-3004817883bus:SmallCompaniesRegimeForAccounts2024-10-012025-09-3004817883bus:FRS1022024-10-012025-09-3004817883bus:AuditExemptWithAccountantsReport2024-10-012025-09-3004817883bus:Director22024-10-012025-09-3004817883bus:FullAccounts2024-10-012025-09-30xbrli:purexbrli:sharesiso4217:GBP